According to Allied Healthcare Products's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.00416667. At the end of 2022 the company had a P/E ratio of -1.22.
Year | P/E ratio | Change |
---|---|---|
2022 | -1.22 | -112.04% |
2021 | 10.2 | -171.8% |
2020 | -14.2 | 299.72% |
2019 | -3.54 | -19.16% |
2018 | -4.38 | -8.86% |
2017 | -4.81 | 124.62% |
2016 | -2.14 | -67.97% |
2015 | -6.68 | -8.65% |
2014 | -7.31 | -57.44% |
2013 | -17.2 | -72.46% |
2012 | -62.4 | -145.77% |
2011 | 136 | -362.18% |
2010 | -52.0 | 2615.27% |
2009 | -1.92 | -103.01% |
2008 | 63.5 | 100.97% |
2007 | 31.6 | 17.52% |
2006 | 26.9 | |
2004 | 21.4 | -111.58% |
2003 | -185 | 6427.88% |
2002 | -2.83 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.